BLANDINO, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.479
EU - Europa 3.286
AS - Asia 2.593
SA - Sud America 538
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 13.250
Nazione #
US - Stati Uniti d'America 6.197
SG - Singapore 1.243
IT - Italia 1.238
CN - Cina 1.011
UA - Ucraina 793
IE - Irlanda 636
BR - Brasile 470
CI - Costa d'Avorio 278
CA - Canada 247
RU - Federazione Russa 174
SE - Svezia 116
VN - Vietnam 98
DE - Germania 69
GB - Regno Unito 65
FR - Francia 58
KR - Corea 53
IN - India 41
AR - Argentina 26
MX - Messico 26
SN - Senegal 25
PL - Polonia 23
CH - Svizzera 20
ID - Indonesia 19
AT - Austria 17
BD - Bangladesh 17
EC - Ecuador 17
NL - Olanda 16
UZ - Uzbekistan 16
HK - Hong Kong 14
IQ - Iraq 14
TR - Turchia 13
CO - Colombia 11
PK - Pakistan 11
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
EU - Europa 9
GR - Grecia 9
JP - Giappone 9
MA - Marocco 9
BE - Belgio 8
ES - Italia 8
EG - Egitto 7
FI - Finlandia 7
LB - Libano 7
IR - Iran 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
KE - Kenya 4
RO - Romania 4
VE - Venezuela 4
BO - Bolivia 3
LT - Lituania 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
DZ - Algeria 2
HN - Honduras 2
MD - Moldavia 2
NO - Norvegia 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 13.250
Città #
Dallas 1.143
Santa Clara 854
Jacksonville 758
Dublin 636
Singapore 625
Chandler 582
Boardman 293
Abidjan 278
Nanjing 217
Chicago 201
Lawrence 181
Toronto 180
Andover 179
Cambridge 179
Ashburn 167
Los Angeles 150
Hefei 138
Beijing 136
San Mateo 124
Wilmington 90
Milan 88
Des Moines 84
Catania 66
Nanchang 61
Shenyang 59
Civitanova Marche 55
Hebei 52
Seoul 52
Jiaxing 51
Rome 49
Ottawa 48
Saint Petersburg 44
Tianjin 39
Ho Chi Minh City 36
Changsha 33
Houston 32
São Paulo 31
Bremen 25
Dakar 25
Columbus 22
Florence 18
Hanoi 18
The Dalles 18
Council Bluffs 17
Rio de Janeiro 17
Boston 16
Moscow 15
Palermo 15
Brooklyn 14
Bologna 13
Hangzhou 13
Belo Horizonte 12
New York 12
Norwalk 12
Phoenix 12
Seattle 12
Stockholm 12
Verona 12
Warsaw 12
Atlanta 11
Cherasco 11
Pune 11
Turin 11
Ann Arbor 10
Genoa 10
Curitiba 9
Dhaka 9
Hong Kong 9
Jinan 9
London 9
Mexico City 9
San Francisco 9
Angri 8
Brussels 8
Chennai 8
Da Nang 8
Den Haag 8
Frankfurt Am Main 8
Jakarta 8
Kunming 8
Ribeirão Preto 8
Segrate 8
Tokyo 8
Ankara 7
Brasília 7
Buffalo 7
Grafing 7
Liberty Lake 7
Modena 7
Montreal 7
Porto Alegre 7
Washington 7
Baghdad 6
Brno 6
Campinas 6
Charlotte 6
Johannesburg 6
Leawood 6
Mumbai 6
Quito 6
Totale 8.659
Nome #
Caratteristiche di adesione di ceppi di Bifidobacterium lactis BB-12, Bifidobacterium longum W11, Bifidobacterium bifidum su cellule epiteliali umane della linea HT-29 999
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 137
Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy 128
3-Methylthio-, 3-(amino-substituted)ethylthio-, 3-carboxymethylthio-, 3,3'-(dithiobis)-5-aryl-4H(R)-1,2,4-triazoles and 2-aminomethyl-N-substituted derivatives of 5-aryl-4H(R)-1,2,4-triazolin-3-thione: synthesis and biological activity 125
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum 122
Batteri anaerobi non sporigeni. In: MICROBIOLOGIA FARMACEUTICA 118
Impact of gut microbiota on diabetes mellitus 108
Ampliamento dello spettro di attività della vancomicina nei confronti di batteri gram-negativi mediante incapsulazione in liposomi fuso genici 108
CARATTERISTICHE DI ADESIONE DI CEPPI DI BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BB-12, BIFIDOBACTERIUM LONGUM W11, BIFIDOBACTERIUM BIFIDUM SU CELLULE EPITELIALI UMANE DELLA LINEA HT-29 105
Microbial and clinical effects of systemic flurithromycin therapy in the treatment of periodontal diseases compared with clinical procedures 103
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 102
Activity of Berberis aetnensis C. Presl. Root extract against Candida strains 99
Microbial evaluation of "in vitro" antibacterial activity of "one stage full mouth" disinfection with clorexidine in adult periodontitis 98
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 95
Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases 94
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections 94
SENSITIVITY TO AUGMENTIN OF ANEROBIC BACTERIA BETA-LACTAMASES PRODUCING. 93
Attività antibatterica di cefprozil nei confronti di Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis e Streptococcus pneumoniae circolanti attualmente in Italia 92
Antimicrobial susceptibility and Beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections 92
Antibacterial activity of medicinal plant extracts against periodontopathic bacteria 90
DIMINUITA PRESENZA DI FATTORI DI VIRULENZA IN ESCHERICHIA COLI UROPATOGENI ANTIBIOTICO-RESISTENTI 90
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 89
Bacilli sporigeni aerobi e anaerobi (cap. 37) 88
BACTERIOLOGICAL STUDIES OF AMOXYCILLIN-CLAVULANIC ACID AGAINST ANEROBIC BACTERIA. 88
Bacilli sporigeni aerobi ed anerobi. In: MICROBIOLOGIA FARMACEUTICA 88
In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates 88
Studio microbiologico dell’attività antibatterica “in vivo” della disinfezione “one stage full mouth” con clorexidina nella terapia della parodontite dell’adulto 87
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 87
Meccanismi patogenetici di ceppi di Prevotella intermedia e Fusobacterium nucleatum isolati da parodontopatie e da infezioni polmonari 87
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 87
Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones 86
Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles 86
Synthesis of 1-aroyl-4H(R)-thiosemicarbazides, the corresponding 5-aryl 4H(R)-1,2,4-triazolin-3-thiones and some derivatives of pharmaceutical interest 85
Microbiological characteristics of kanendomycin [Caratteristiche microbiologiche della kanendomicina] 85
Antimicrobial susceptibility of Lactobacillus strains used in probiotic products 85
Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens 85
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints 85
Dental implants with locking taper connection versus screwed connection: microbiologic and scanning electron microscope study 84
Synthesis and preliminary biological investigation of 2,6-diaryl substituted imidazo(1,2-b)-1,3-4-thiadiazoles [SINTES]I E VALUTAZIONE BIOLOGICA PRELIMINARE DI IMIDAZO[2,1-b]-1,3,4-TIADIAZOLI-2,6-DIARILSOSTITUITI 84
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 84
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 83
Identification and characterization of Lactobacillus paracasei strain with probiotic properties isolated from faeces of healthy adult volunteers 82
Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery 82
Uso di prebiotici e probiotici ed ecosistema microbico intestinale 81
Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin 81
Synthesis, spectral behaviour and microbiological properties of some di(nitrothienyl)sulfides. 81
In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections 81
Probiotics:overview of microbiological and immunological characteristics 81
Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis 81
Predictive value of bacterial analysis of laparotomy wounds 81
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 81
Osservatorio Epidemiologico Italiano. Patogeni respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 80
Osservatorio Epidemiologico Italiano: analisi del secondo anno di monitoraggio delle resistenze agli antibiotici in Haemophilus influenzae e Haemophilus parainfluenzae 80
Bacteriological findings and antimicrobial resistance in odontogenic and non odontogenic chronic maxillary sinusitis 79
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and beta-lactamase production 79
Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy 78
SURGICAL SITE INFECTION IN ELDERLY PATIENTS 78
Study on the adhesion characterstics of Bifidobacterium spp.strains on human epithelial cell line HT-29. 78
Epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated from 2001 to 2005 in Catania 78
Incidence of non-fermenting gram-negative bacilli in infected patients 77
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 77
Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut 77
Intercellular communication during yeast cell growth 76
Susceptibility of clinical isolates of Haemophilus to new 4-quinolones 76
Microbiological intraoperative results in short-term prophylaxis (aztreonam or gentamicin) in abdominal surgery 76
Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections 76
Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain 76
Correlations between bacterial flora present in the juice and the gastric mucosa and the risk of postoperative infection [Correlazione tra flora batterica presente nel succo e nella mucosa gastrica e rischio di infezione postoperatoria] 75
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 75
Effetto prebiotico di Opuntia ficus-indica (L.) nei confronti di alcuni ceppi di Lactobacillus e Bifidobacterium isolati da prodotti probiotici farmaceutici 75
Probiotici e Prebiotici:dalla ricerca al consumatore 75
Prevenzione e controllo delle infezioni in chirurgia gastrica 74
Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery 74
CT findings in hepatic involvement by Echinococcus granulosus 74
PRODUZIONE DI B-LATTAMASI ED ANTIBIOTICO SENSIBILITA’ DI GERMI ANAEROBI. 74
Studio microbiologico dell'attività "in vivo"della disinfezione "one stage full mouth"con clorexidina nella terapia della parodontite dell'adulto 73
Evaluation of the antibacterial effect of cefsulodin against Pseudomonadaceae [Valutazione dell'attività antibatterica del cefsulodin nei confronti di Pseudomonadaceae] 73
Immunizzazione passiva naturale e artificiale. In: MICROBIOLOGIA FARMACEUTICA 73
Impianti dentali a connessione conometrica versus impianti dentali a connessione avvitata:studio microbiologico e al microscopio elettronico a scansione 72
Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units [Azione antimicotica di alcuni diaril solfuri a catena aperta e ciclici contenenti unità piridiniche e tiadiazoliche] 72
Caratteristiche microbiologiche e terapeutiche dei batteri probiotici 72
L'ambiente intestinale e la disbiosi 72
Parodontopatia dell'adulto: 3 terapie a confronto 71
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 71
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 70
Susceptibility of molecularly characterizeted hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin 70
Virulence factors and antibiotic resistance in uropathogenic Escherichia coli 70
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 70
Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains 70
In vitro activity of imipenem towards gram-negative bacilli 69
Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam) 69
Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination 68
Incidence of fermentative and non-fermentative gram-negative bacilli in an intensive care environment [Incidenza di bacilli gram-negativi fermentanti e non fermentanti in ambiente nosocomiale di terapia intensiva] 67
In vitro susceptibility of Arcobacter butzleri and Arcobacter cryaerophilus to different antimicrobial agents 67
Incidence and antibiotic-resistance of gram-negative species isolated from burns [Incidenza antibiotico-resistenza di specie batteriche gram-negative isolate in ustionati] 66
Internalization–associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis 66
Batteri anaerobi non sporigeni (cap. 38) 65
Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin 64
Reduced delta-haemolysin activity and agr-expression correlate with an hVISA/VISA phenotype. 64
Epidemiology of antibiotic resistance in human isolates of Enterobacteriaceae in Sicily 63
Totale 9.189
Categoria #
all - tutte 44.155
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.155


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021963 0 0 0 0 353 46 159 15 145 17 173 55
2021/20221.389 197 185 13 33 209 8 201 44 161 3 54 281
2022/20231.932 190 62 26 133 244 346 14 305 514 23 57 18
2023/2024801 49 116 39 66 36 79 29 60 23 48 163 93
2024/20253.171 39 489 201 145 792 272 36 123 251 327 190 306
2025/20262.925 444 399 1.414 386 282 0 0 0 0 0 0 0
Totale 13.498